Literature DB >> 24848836

Imaging-guided percutaneous cryotherapy of bone and soft-tissue tumors: what is the impact on the muscles around the ablation site?

Fabrice Bing1, Julien Garnon, Georgia Tsoumakidou, Iulian Enescu, Nitin Ramamurthy, Afshin Gangi.   

Abstract

OBJECTIVE: The objectives of our study were to evaluate the incidence of muscular injury after cryoablation of bone and soft-tissue tumors, to relate MRI findings to the size of the intramuscular ice ball, and to determine the clinical significance of postcryotherapy myositis.
MATERIALS AND METHODS: Between January 2010 and October 2012, 24 bone and soft-tissue lesions (16 pelvic lesions, three shoulder lesions, and five paravertebral lesions) in 21 patients treated by imaging-guided percutaneous cryoablation and followed up with MRI were retrospectively analyzed. Muscular hyperintensity on T2 STIR images was graded as follows: grade 0, no myositis; grade 1, local myositis; grade 2, myositis in less than half of the volume of the muscle; or grade 3, myositis in half of the volume of the muscle or more. The presence of T2 STIR hyperintensity in the muscles surrounding the cryoablation site was correlated with the volume of the intramuscular ice ball.
RESULTS: Muscular T2 STIR hyperintensity was observed in 87.5% of cases (grade 0 in 12.5%, grade 1 in 45.8%, grade 2 in 20.8%, and grade 3 in 20.8%). The volume of the intramuscular ice ball and grade of myositis (mean volume: grade 0, 2.8 cm(3); grade 1, 9.2 cm(3); grade 2, 17.1 cm(3); grade 3, 42.9 cm(3)) were positively correlated in the 24 lesions in the study cohort (r = 0.64, p < 0.001). Only two cases of myositis (grade 3) were symptomatic, and antiinflammatory drugs promoted pain resolution in both cases.
CONCLUSION: Muscular injury around the cryoablation site is commonly observed and is correlated with the volume of the ice ball. When muscular injury around the cryoablation site causes pain, the symptoms differ from the initial tumoral pain and can be treated with antiinflammatory drugs.

Entities:  

Mesh:

Year:  2014        PMID: 24848836     DOI: 10.2214/AJR.13.11430

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.

Authors:  Raja Shaikh; Ahmad I Alomari; Cindy L Kerr; Patricia Miller; Samantha A Spencer
Journal:  Pediatr Radiol       Date:  2016-02-22

Review 2.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

Review 3.  Percutaneous image-guided cryoablation: current applications and results in the oncologic field.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Nitin Ramamurthy; Guillaume Koch; Georgia Tsoumakidou; Jean Caudrelier; Francesco Arrigoni; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Afshin Gangi
Journal:  Med Oncol       Date:  2016-11-11       Impact factor: 3.064

4.  MR-Guided Microwave Ablation for Lung Malignant Tumor: A Single Center Prospective Study.

Authors:  Ruixiang Lin; Yan Fang; Jin Chen; QingFeng Lin; Jian Chen; Yuan Yan; Jie Chen; Zhengyu Lin
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

5.  CT-guided cryoablation for unresectable pelvic recurrent colorectal cancer: a retrospective study.

Authors:  Ying Wang; Xin-Hong He; Li-Chao Xu; Hao-Zhe Huang; Guo-Dong Li; Yao-Hui Wang; Wen-Tao Li; Guang-Zhi Wang
Journal:  Onco Targets Ther       Date:  2019-02-19       Impact factor: 4.147

6.  Hybrid treatment of fibroadipose vascular anomaly: A case report.

Authors:  Francesco Stillo; Federica Ruggiero; Antonio De Fiores; Rita Compagna; Bruno Amato
Journal:  Open Med (Wars)       Date:  2020-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.